X hits on this document

Powerpoint document

PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES - page 23 / 38

143 views

0 shares

0 downloads

0 comments

23 / 38

Antiplatlet Agents-Secondary Prevention, Class 1

ASA in existing CVD reduces subsequent risk by 25%

Unless contraindicated, ASA should be used by most patients

Clopidigril and ticlopidine should be considered for patients with ASA allergy or intolerance

Cost

ASA $11,000/QALY

Clopidigril $130,000/QALY

Document info
Document views143
Page views143
Page last viewedMon Jan 23 19:49:49 UTC 2017
Pages38
Paragraphs624
Words2577

Comments